CoChat

von Hippel-Lindau disease: Updated guideline for diagnosis and surveillance

Louise M Binderup, Marie, Smerdel, Maja, Borgwadt, Line, Beck Nielsen, Signe Sparre, Madsen, Mia Gebauer, Møller, Hans Ulrik, Kiilgaard, Jens Folke, Friis-Hansen, Lennart, Harbud, Vibeke, Cortnum, Søren, Owen, Hanne, Gimsing, Steen, Friis Juhl, Henning Anker, Munthe, Sune, Geilswijk, Marianne, Rasmussen, Åse Krogh, Møldrup, Ulla, Graumann, Ole, Donskov, Frede, Grønbæk, Henning, Stausbøl-Grøn, Brian, Schaffalitzky de Muckadell, Ove, Knigge, Ulrich, Dam, Gitte, Wadt, Karin AW., Bøgeskov, Lars, Bagi, Per, Lund, Lars, Stochholm, Kirstine, Ousager, Lilian Bomme, Sunde, Lone · 2022 · European Journal of Medical Genetics
Cited by 120

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ejmg.2022.104538

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 62

  1. Bausch, 2013, Renal cancer in von Hippel-Lindau disease and related syndromes, Nat. Rev. Nephrol., 9, 529, 10.1038/nrneph.2013.144 · DOI
  2. Bertelsen, 2010, 153, 35
  3. Binderup, 2013, Von Hippel-Lindau disease (vHL). National clinical guideline for diagnosis and surveillance in Denmark, Dan Med J, 60, B4763
  4. Binderup, 2015, New von Hippel-Lindau manifestations develop at the same or decreased rates in pregnancy, Neurology, 85, 1500, 10.1212/WNL.0000000000002064 · doi:10.1212/wnl.0000000000002064
  5. Binderup, 2015, Risk of new tumors in von Hippel-Lindau patients depends on age and genotype, Genet. Med., 18, 89, 10.1038/gim.2015.44 · DOI
  6. Binderup, 2016, Prevalence, birth incidence, and penetrance of von Hippel-Lindau disease (vHL) in Denmark, Eur. J. Hum. Genet., 25, 301, 10.1038/ejhg.2016.173 · DOI
  7. Binderup, 2017, Survival and causes of death in patients with von Hippel-Lindau disease, J. Med. Genet., 54, 11, 10.1136/jmedgenet-2016-104058 · DOI · Paper page
  8. Binderup, 2018, von Hippel-Lindau disease: diagnosis and factors influencing disease outcome, Dan Med J, 65
  9. Blansfield, 2007, Clinical, genetic and radiographic analysis of 108 patients with von Hippel-Lindau disease (VHL) manifested by pancreatic neuroendocrine neoplasms (PNETs), Surgery, 142, 814, 10.1016/j.surg.2007.09.012 · doi:10.1016/j.surg.2007.09.012
  10. Bui, 2021, Scanxiety: a scoping review about scan-associated anxiety, BMJ Open, 11, 10.1136/bmjopen-2020-043215 · DOI
  11. Cascon, 2007, Loss of the actin regulator HSPC300 results in clear cell renal cell carcinoma protection in Von Hippel-Lindau patients, Hum. Mutat., 28, 613, 10.1002/humu.20496 · DOI
  12. Chahoud, 2020, Evaluation, diagnosis and surveillance of renal masses in the setting of VHL disease, World J. Urol., 39, 2409, 10.1007/s00345-020-03441-3 · DOI
  13. Cybulski, 2002, Germline mutations in the von Hippel-Lindau (VHL) gene in patients from Poland: disease presentation in patients with deletions of the entire VHL gene, J. Med. Genet., 39, E38, 10.1136/jmg.39.7.e38 · DOI
  14. Decker, 2014, Clinical utility gene card for: von Hippel-Lindau (VHL), Eur. J. Hum. Genet., 22, 10.1038/ejhg.2013.180 · DOI
  15. Evans, 2010, Birth incidence and prevalence of tumor-prone syndromes: estimates from a UK family genetic register service, Am. J. Med. Genet., 152A, 327, 10.1002/ajmg.a.33139 · DOI · Paper page
  16. Falconi, 2016, ENETS consensus guidelines update for the management of patients with functional pancreatic neuroendocrine tumors and non-functional pancreatic neuroendocrine tumors, Neuroendocrinology, 103, 153, 10.1159/000443171 · DOI · Paper page
  17. Feletti, 2016, Von Hippel-Lindau disease: an evaluation of natural history and functional disability, Neuro Oncol., 18, 1011, 10.1093/neuonc/nov313 · DOI
  18. Franke, 2009, Alu-Alu recombination underlies the vast majority of large VHL germline deletions: molecular characterization and genotype-phenotype correlations in VHL patients, Hum. Mutat., 30, 776, 10.1002/humu.20948 · DOI
  19. Frantzen, 2012, Pregnancy-related hemangioblastoma progression and complications in von Hippel-Lindau disease, Neurology, 79, 793, 10.1212/WNL.0b013e3182661f3c · doi:10.1212/wnl.0b013e3182661f3c
  20. Fraser, 2007, Study comparing two types of screening provision for people with von Hippel-Lindau disease, Fam. Cancer, 6, 103, 10.1007/s10689-006-9111-y · doi:10.1007/s10689-006-9111-y
  21. Glasker, 1999, The impact of molecular genetic analysis of the VHL gene in patients with haemangioblastomas of the central nervous system, J. Neurol. Neurosurg. Psychiatry, 67, 758, 10.1136/jnnp.67.6.758 · DOI
  22. Gonzalez-Rodriguez, 2019, Evaluation of the safety and effectiveness of oral propranolol in patients with von Hippel-Lindau disease and retinal hemangioblastomas: phase III clinical trial, BMJ Open Ophthalmol., 4, 10.1136/bmjophth-2018-000203 · DOI
  23. Gossage, 2015, VHL, the story of a tumour suppressor gene, Nat. Rev. Cancer, 15, 55, 10.1038/nrc3844 · DOI · Paper page
  24. Hammel, 2000, Pancreatic involvement in von Hippel-Lindau disease. The Groupe Francophone d'Etude de la Maladie de von Hippel-Lindau, Gastroenterology, 119, 1087, 10.1053/gast.2000.18143 · DOI · Paper page
  25. Hes, 2005, Von hippel-lindau disease, Hered. Cancer Clin. Pract., 3, 171, 10.1186/1897-4287-3-4-171 · DOI
  26. Hes, 2007, Frequency of Von Hippel-Lindau germline mutations in classic and non-classic Von Hippel-Lindau disease identified by DNA sequencing, Southern blot analysis and multiplex ligation-dependent probe amplification, Clin. Genet., 72, 122, 10.1111/j.1399-0004.2007.00827.x · DOI
  27. Hes, 2001, Clinical management of von hippel-lindau (VHL) disease, Neth. J. Med., 59, 225, 10.1016/S0300-2977(01)00165-6 · doi:10.1016/s0300-2977(01)00165-6
  28. Huntoon, 2021, Hemangioblastoma diagnosis and surveillance in von Hippel-Lindau disease: a consensus statement, J. Neurosurg., 1
  29. Jasim, 2020, Metastatic pheochromocytoma and paraganglioma: management of endocrine manifestations, surgery and ablative procedures, and systemic therapies, Best Pract. Res. Clin. Endocrinol. Metabol., 34, 10.1016/j.beem.2019.101354 · DOI
  30. Kasparian, 2015, Through the looking glass: an exploratory study of the lived experiences and unmet needs of families affected by Von Hippel-Lindau disease, Eur. J. Hum. Genet., 23, 34, 10.1038/ejhg.2014.44 · DOI
  31. Kruizinga, 2014, Calculating optimal surveillance for detection of von Hippel-Lindau-related manifestations, Endocr. Relat. Cancer, 21, 63, 10.1530/ERC-13-0308 · DOI
  32. Lammens, 2011, Compliance with periodic surveillance for Von-Hippel-Lindau disease, Genet. Med., 13, 519, 10.1097/GIM.0b013e3182091a1d · DOI
  33. Launbjerg, 2017, von Hippel-Lindau development in children and adolescents, Am. J. Med. Genet., 173, 2381, 10.1002/ajmg.a.38324 · doi:10.1002/ajmg.a.38324
  34. Lonser, 2014, Prospective natural history study of central nervous system hemangioblastomas in von Hippel-Lindau disease, J. Neurosurg., 120, 1055, 10.3171/2014.1.JNS131431 · DOI · Paper page
  35. Lonser, 2003, von Hippel-Lindau disease, Lancet, 361, 2059, 10.1016/S0140-6736(03)13643-4 · DOI · Paper page
  36. Maddock, 1996, A genetic register for von Hippel-Lindau disease, J. Med. Genet., 33, 120, 10.1136/jmg.33.2.120 · DOI · Paper page
  37. Maher, 1991, Von Hippel-Lindau disease: a genetic study, J. Med. Genet., 28, 443, 10.1136/jmg.28.7.443 · DOI · Paper page
  38. Maher, 2011, von Hippel-Lindau disease: a clinical and scientific review, Eur. J. Hum. Genet., 19, 617, 10.1038/ejhg.2010.175 · DOI · Paper page
  39. Maranchie, 2004, Solid renal tumor severity in von Hippel Lindau disease is related to germline deletion length and location, Hum. Mutat., 23, 40, 10.1002/humu.10302 · DOI
  40. McNeill, 2009, Genotype-phenotype correlations in VHL exon deletions, Am. J. Med. Genet., 149A, 2147, 10.1002/ajmg.a.33023 · DOI
  41. Melmon, 1964, LINDAU'S disease. Review of the literature and study of a large kindred, Am. J. Med., 36, 595, 10.1016/0002-9343(64)90107-X · doi:10.1016/0002-9343(64)90107-x
  42. Mehta, 2021, Endolymphatic sac tumor screening and diagnosis in von Hippel-lindau disease: a consensus statement, J Neurol Surg B
  43. Moller, 1930, Familiær Angiomatosis retinae et cerebelli -Lindau's Sygdom, Ugeskr Laeger, 92, 379
  44. Moller, 1952, Another family with von Hippel-Lindau's disease, Acta Ophthalmol., 30, 10.1111/j.1755-3768.1952.tb07650.x · doi:10.1111/j.1755-3768.1952.tb07650.x
  45. Neumann, 1991, Clustering of features of von Hippel-Lindau syndrome: evidence for a complex genetic locus, Lancet, 337, 1052, 10.1016/0140-6736(91)91705-Y · DOI · Paper page
  46. Nordstrom-O'Brien, 2010, Genetic analysis of von Hippel-Lindau disease, Hum. Mutat., 31, 521
  47. Pavel, 2016, ENETS consensus guidelines update for the management of distant metastatic disease of intestinal, pancreatic, bronchial neuroendocrine neoplasms (NEN) and NEN of unknown primary site, Neuroendocrinology, 103, 172, 10.1159/000443167 · DOI · Paper page
  48. Poulsen, 2010, Surveillance in von Hippel-Lindau disease (vHL), Clin. Genet., 77, 49, 10.1111/j.1399-0004.2009.01281.x · doi:10.1111/j.1399-0004.2009.01281.x
  49. Poulsen, 2011, von Hippel-Lindau disease: surveillance strategy for endolymphatic sac tumors, Genet. Med., 13, 1032, 10.1097/GIM.0b013e31822beab1 · doi:10.1097/gim.0b013e31822beab1
  50. Rasmussen, 2010, Uptake of genetic testing and long-term tumor surveillance in von Hippel-Lindau disease, BMC Med. Genet., 11, 4, 10.1186/1471-2350-11-4 · doi:10.1186/1471-2350-11-4
  51. Rednam, 2017, Von hippel-lindau and hereditary pheochromocytoma/paraganglioma syndromes: clinical features, genetics, and surveillance recommendations in childhood, Clin. Cancer Res., 23, e68, 10.1158/1078-0432.CCR-17-0547 · DOI · Paper page
  52. Salama, 2019, Comprehensive characterization of a Canadian cohort of von Hippel-lindau disease patients, Clin. Genet., 10.1111/cge.13613 · DOI
  53. Sgambati, 2000, Mosaicism in von Hippel-Lindau disease: lessons from kindreds with germline mutations identified in offspring with mosaic parents, Am. J. Hum. Genet., 66, 84, 10.1086/302726 · DOI · Paper page
  54. Singh, 2001, Retinal capillary hemangioma: a comparison of sporadic cases and cases associated with von Hippel-Lindau disease, Ophthalmology, 108, 1907, 10.1016/S0161-6420(01)00758-8 · doi:10.1016/s0161-6420(01)00758-8
  55. Wang, 2018, Risk factors for survival in patients with von Hippel-Lindau disease, J. Med. Genet., 55, 322, 10.1136/jmedgenet-2017-104995 · doi:10.1136/jmedgenet-2017-104995
  56. Wang, 2017, Shorter telomere length increases age-related tumor risks in von Hippel-Lindau disease patients, Cancer Med., 6, 2131, 10.1002/cam4.1134 · DOI
  57. Wiley, 2019, Management of retinal hemangioblastoma IN VON hippel-lindau disease, Retina, 39, 2254, 10.1097/IAE.0000000000002572 · DOI
  58. Wind, 2011, Management of von Hippel-Lindau disease-associated CNS lesions, Expert Rev. Neurother., 11, 1433, 10.1586/ern.11.124 · doi:10.1586/ern.11.124
  59. Ye, 2012, Effect of pregnancy on hemangioblastoma development and progression in von Hippel-Lindau disease, J. Neurosurg., 117, 818, 10.3171/2012.7.JNS12367 · doi:10.3171/2012.7.jns12367
  60. Yoon, 2022, Genetic counseling and long-term surveillance using a multidisciplinary approach in von Hippel-lindau disease, Ann. Lab. Med., 42, 352, 10.3343/alm.2022.42.3.352 · DOI
  61. Yu, 2019, Allosteric inhibition of HIF-2alpha as a novel therapy for clear cell renal cell carcinoma, Drug Discov. Today, 24, 2332, 10.1016/j.drudis.2019.09.008 · DOI
  62. Zhang, 2021, Clinical characteristics and risk factors for survival in affected offspring of von Hippel-Lindau disease patients, J. Med. Genet.

Metadata

Authors
Louise M Binderup, M., Smerdel, M., Borgwadt, L., Beck Nielsen, S. S., Madsen, M. G., Møller, H. U., Kiilgaard, J. F., Friis-Hansen, L., Harbud, V., Cortnum, S., Owen, H., Gimsing, S., Friis Juhl, H. A., Munthe, S., Geilswijk, M., Rasmussen, Å. K., Møldrup, U., Graumann, O., Donskov, F., Grønbæk, H., Stausbøl-Grøn, B., Schaffalitzky de Muckadell, O., Knigge, U., Dam, G., Wadt, K. A., Bøgeskov, L., Bagi, P., Lund, L., Stochholm, K., Ousager, L. B., & Sunde, L.
Venue
European Journal of Medical Genetics
Publisher
Elsevier BV
Published
2022-08
Volume
65
Issue
8
Pages
104538
ISSN
1769-7212
Cited by
120
References
6
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.